Market LIVE
Published markets; coverage varies by country
Product profile · United States

XPOVIO

 ·  Patent Litigation & Settlement History ↓

IngredientSELINEXOR
Application typeNDA
Application212306
Product004
Dosage formTABLET
RouteORAL
Strength60MG
Approval date2021-04-15
Marketing statusPrescription
Status event—
ApplicantKARYOPHARM THERAPS
Product source

Current GenericRadar decision

Year2033
SelectionDEEP_REVIEW
ReviewFINAL
Anchor typePATENT
Anchor date2033-07-03
Patent anchor2033-07-03
Exclusivity anchor2026-07-03
Protection date2035-08-14
First Final ANDA—
Status event—

GNR judgment: DEEP_REVIEW. Reference year: 2033. Anchor type: PATENT. Patent anchor: 2033-07-03. Exclusivity anchor: 2026-07-03. Anchor date: 2033-07-03. Patent tail: yes. Exclusivity tail: no. Review status: FINAL. Historical detailed rationale is retained in the evidence snapshot; this is a structured English summary, not a literal translation.

Patent estate

PatentEffective dateOfficial listingTRUE_DSDS gradeClaim classification / basisPTEPEDFamily
105441082032-07-26U U-3018NYU
English description not available.
———
105441082032-07-26U U-2584NYU
English description not available.
———
105441082032-07-26ORANGE_BOOK U-2584;U-3018NYU
English description not available.
———
110346602032-07-26U U-3018NYU
English description not available.
———
110346602032-07-26U U-2584NYU
English description not available.
———
110346602032-07-26ORANGE_BOOK U-2584;U-3018NYU
English description not available.
———
117877712032-07-26U U-3018NYU
English description not available.
———
117877712032-07-26U U-2584NYU
English description not available.
———
117877712032-07-26ORANGE_BOOK U-2584;U-3018NYU
English description not available.
———
122915082032-07-26U U-2584NYU
English description not available.
———
122915082032-07-26U U-3018NYU
English description not available.
———
122915082032-07-26ORANGE_BOOK U-2584;U-3018NYU
English description not available.
———
90798652032-07-26U U-3018NYU
English description not available.
———
90798652032-07-26U U-2584NYU
English description not available.
———
90798652032-07-26ORANGE_BOOK U-2584;U-3018NYU
English description not available.
———
97142262032-07-26DS/DP —YNTRUE_DS
English description not available.
———
97142262032-07-26ORANGE_BOOK —YNTRUE_DS
English description not available.
———
89999962033-07-03DS/DP —YNTRUE_DS
English description not available.
———
89999962033-07-03ORANGE_BOOK —YNTRUE_DS
English description not available.
———
105191392035-08-14DS/DP/U U-3018NNDP
English description not available.
———
105191392035-08-14DS/DP/U U-2584NNDP
English description not available.
———
105191392035-08-14ORANGE_BOOK U-2584;U-3018NNDP
English description not available.
———
117461022035-08-14U U-2584NNU
English description not available.
———
117461022035-08-14U U-3018NNU
English description not available.
———
117461022035-08-14ORANGE_BOOK U-2584;U-3018NNU
English description not available.
———
117534012035-08-14DP/U U-3018NNDP
English description not available.
———
117534012035-08-14DP/U U-2584NNDP
English description not available.
———
117534012035-08-14ORANGE_BOOK U-2584;U-3018NNDP
English description not available.
———
118076292035-08-14DS/DP —NNDP
English description not available.
———
118076292035-08-14ORANGE_BOOK —NNDP
English description not available.
———

Regulatory exclusivity

CodeStart dateEnd dateScopeEntire productAll indicationsFull coverage dateCombinationSource
NCE2019-07-032024-07-03English description not available.YY2024-07-03
ODE-257 + ODE-346
Full coverage date: 2024-07-03
Source
ODE-2572019-07-032026-07-03English description not available.NN—
ODE-257 + ODE-346
Full coverage date: —
Source
ODE*—2026-07-03————Source
ODE-3102020-06-222027-06-22English description not available.NN—
ODE-257 + ODE-346
Full coverage date: —
Source
ODE*—2027-06-22————Source
ODE-3462020-12-182027-12-18English description not available.NN—
ODE-257 + ODE-346
Full coverage date: —
Source
ODE*—2027-12-18————Source

2026-10-10 · CURRENT_SOURCE_RECORDS_FOUND · Historical coverage: NOT_COMPLETE

Generic approval evidence

Application / productEventFinal dateTentative dateApplicantAuthorized genericExact mappingSource
No generic approval facts are linked to this product.

Market Entry Information

API filings, authorized generics and linked regulatory milestones.

API Master Files & Certifications 0 records

Ingredient-level registrations from linked public manufacturer portfolios. A filing does not establish supply to this finished product. DMFs are not FDA approvals.

APIHolder / manufacturerHolder countryFiling typeNumberStatusFiled dateAvailable for referenceSourceLast verified
No master-file or certification records are linked through public manufacturer portfolios.

Authorized Generics 0 records

Authorized generics are shown separately from independent ANDA approvals.

Application / productApplicantEvent / status First marketed Product mappingSourceLast verified
No authorized-generic records are linked to this product.

Tentative ANDA Approvals 0 records

Tentative approval is not final approval. Historical tentative approvals remain visible after a linked final approval.

Application / productApplicantEvent / status Tentative date Follow-up final approvalProduct mappingSourceLast verified
No tentative-approval records are linked to this product.

Paragraph IV Challenges 0 records

Paragraph IV challenges below are sourced from legal records separately from FDA approvals. An ANDA filing, lawsuit or settlement does not establish final approval or commercial launch.

Application / productApplicantEvent / status Certification event date Product mappingSourceLast verified
No structured Paragraph IV certification events are linked in the available approval evidence.

Final ANDA Approvals 0 records

Approval dates do not establish commercial launch. Product mapping is shown for each linked record.

Application / productApplicantEvent / status Final approval date Product mappingSourceLast verified
No final-approval records are linked to this product.
Decision evidence (16)
TypeDateRoleBasisSource
PATENT2032-07-26HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2032-07-26HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2032-07-26HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2032-07-26HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2032-07-26HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2032-07-26HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2033-07-03CANONICAL_ANCHOREnglish description not available.Source
PATENT2035-08-14FTO_TAILEnglish description not available.Source
PATENT2035-08-14FTO_TAILEnglish description not available.Source
PATENT2035-08-14FTO_TAILEnglish description not available.Source
PATENT2035-08-14FTO_TAILEnglish description not available.Source
REGULATORY_EXCLUSIVITY—REGULATORY_SCOPE_CONTEXTEnglish description not available.Source
REGULATORY_EXCLUSIVITY—REGULATORY_SCOPE_CONTEXTEnglish description not available.Source
REGULATORY_EXCLUSIVITY—HISTORICAL_CONTEXTEnglish description not available.Source
REGULATORY_EXCLUSIVITY—REGULATORY_SCOPE_CONTEXTEnglish description not available.Source
REGULATORY_STATUS2033-07-03CANONICAL_DECISIONEnglish description not available.Source
Independent legal-event information

Litigation & Settlement History

Settlement launch rights generally apply only to the named parties and product scope. These records do not change GenericRadar patent/exclusivity anchors or current decisions.

No litigation or settlement record currently linked to this product.